Related Experiment Video
Updated: Jul 11, 2026
10:41
Identifying Amino Acid Overproducers Using Rare-Codon-Rich Markers
Published on: June 24, 2019
OuaSelect, a novel ouabain-resistant human marker gene that allows efficient cell selection within 48 h
1Department of Medicine, Division of Hematology, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden.
Gene Therapy
|September 28, 2007
Summary
A novel gene-editing technique utilizes mutations in the Na(+)/K(+)-ATPase alpha1 subunit to create a highly resistant cell line. This OuaSelect marker enables rapid and efficient selection of gene-modified cells for therapy and research.
Area of Science:
- Biotechnology
- Molecular Biology
- Gene Therapy
Background:
- Efficient selection of gene-modified cells is crucial for gene therapy and molecular biology.
- Current selection methods lack ideal speed, efficiency, and clinical compatibility.
Purpose of the Study:
- To identify a novel selection marker with high speed, efficiency, and clinical applicability.
- To engineer a resistant Na(+)/K(+)-ATPase alpha1 subunit for ouabain-based cell selection.
Main Methods:
- Screening of the Na(+)/K(+)-ATPase alpha1 subunit for mutations conferring ouabain resistance.
- Introduction of Q118R and N129D amino acid substitutions.
- Testing resistance in various cell lines and primary cells, including lymphocytes.
Main Results:
- Two amino acid substitutions (Q118R and N129D) conferred a two-log greater resistance to ouabain.
- Transduced primary lymphocytes achieved >99% purity with >80% recovery after 48h of ouabain exposure.
- The engineered alpha1(Q118R/N129D) (OuaSelect) demonstrated significant resistance.
Conclusions:
- The OuaSelect marker provides a safe, rapid, and cost-effective method for selecting gene-modified cells.
- This offers a promising tool for clinical gene therapy and molecular biology research.
- OuaSelect addresses the need for improved cell selection strategies.
